董甦伟团队在糖基化修饰调控β淀粉样多肽聚集机制研究中取得进展

中国药学(英文版) ›› 2021, Vol. 30 ›› Issue (12): 1008-1009.

董甦伟团队在糖基化修饰调控β淀粉样多肽聚集机制研究中取得进展

北京大学药学院天然药物及仿生药物国家重点实验室

北京大学药学院天然药物及仿生药物国家重点实验室

收稿日期:2021-12-12 修回日期:2021-12-13 接受日期:2021-12-15 出版日期:2021-12-24 发布日期:2021-12-25

The group of Professor Suwei Dong have made progress in the study of the mechanism of O-glycosylation modification regulating the aggregation of Amyloid-β

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center

Received:2021-12-12 Revised:2021-12-13 Accepted:2021-12-15 Online:2021-12-24 Published:2021-12-25

摘要/Abstract

摘要：

近日, 学术期刊《Journal of the American Chemical Society》在线发表了北京大学药学院天然药物及仿生药物国家重点实验室董甦伟团队题为 “O-Glycosylation Induces Amyloid-β to Form New Fibril Polymorphs Vulnerable for Degradation” (O-糖基化诱导β淀粉样多肽形成新的易降解纤维聚集体)的研究成果。

Supporting:

北京大学药学院天然药物及仿生药物国家重点实验室. 董甦伟团队在糖基化修饰调控β淀粉样多肽聚集机制研究中取得进展[J]. 中国药学(英文版), 2021, 30(12): 1008-1009.

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The group of Professor Suwei Dong have made progress in the study of the mechanism of O-glycosylation modification regulating the aggregation of Amyloid-β[J]. Journal of Chinese Pharmaceutical Sciences, 2021, 30(12): 1008-1009.